Sabalones, Liliosa M.
HRN: 22-58-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/14/2023
CEFTRIAXONE 1G (VIAL)
02/14/2023
02/21/2023
IV
1g
Q12
Compression Fracture
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes